176 related articles for article (PubMed ID: 19205707)
1. Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma.
Gong Z; Bostick RM; Xie D; Hurley TG; Deng Z; Dixon DA; Zhang J; Hebert JR
Int J Colorectal Dis; 2009 Jun; 24(6):647-54. PubMed ID: 19205707
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
Barry EL; Sansbury LB; Grau MV; Ali IU; Tsang S; Munroe DJ; Ahnen DJ; Sandler RS; Saibil F; Gui J; Bresalier RS; McKeown-Eyssen GE; Burke C; Baron JA
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2726-33. PubMed ID: 19755647
[TBL] [Abstract][Full Text] [Related]
3. Linkage disequilibrium and haplotype analysis of COX-2 and risk of colorectal adenoma development.
Kwagyan J; Apprey V; Ashktorab H
Clin Transl Sci; 2012 Feb; 5(1):60-4. PubMed ID: 22376259
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study.
Ueda N; Maehara Y; Tajima O; Tabata S; Wakabayashi K; Kono S
Cancer Sci; 2008 Mar; 99(3):576-81. PubMed ID: 18167131
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of Cox-2 allelic variants on risk of colorectal adenoma development in African Americans.
Ashktorab H; Tsang S; Luke B; Sun Z; Adam-Campbell L; Kwagyan J; Poirier R; Akter S; Akhgar A; Smoot D; Munroe DJ; Ali IU
Anticancer Res; 2008; 28(5B):3119-23. PubMed ID: 19031967
[TBL] [Abstract][Full Text] [Related]
6. Common polymorphisms in 5-lipoxygenase and 12-lipoxygenase genes and the risk of incident, sporadic colorectal adenoma.
Gong Z; Hebert JR; Bostick RM; Deng Z; Hurley TG; Dixon DA; Nitcheva D; Xie D
Cancer; 2007 Mar; 109(5):849-57. PubMed ID: 17236225
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available?
Pereira C; Medeiros RM; Dinis-Ribeiro MJ
Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):76-91. PubMed ID: 19060633
[TBL] [Abstract][Full Text] [Related]
8. COX1 and COX2 polymorphisms and gastric cancer risk in a Polish population.
Hou L; Grillo P; Zhu ZZ; Lissowska J; Yeager M; Zatonski W; Zhu G; Baccarelli A; Chanock SJ; Fraumeni JF; Chow WH
Anticancer Res; 2007; 27(6C):4243-7. PubMed ID: 18214026
[TBL] [Abstract][Full Text] [Related]
9. Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption.
Siezen CL; van Leeuwen AI; Kram NR; Luken ME; van Kranen HJ; Kampman E
Carcinogenesis; 2005 Feb; 26(2):449-57. PubMed ID: 15550453
[TBL] [Abstract][Full Text] [Related]
10. Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.
Ali IU; Luke BT; Dean M; Greenwald P
Br J Cancer; 2005 Oct; 93(8):953-9. PubMed ID: 16205694
[TBL] [Abstract][Full Text] [Related]
11. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
12. Associations between single nucleotide polymorphisms of COX-2 and MMP-2 genes and colorectal cancer susceptibility in the Saudi population.
Shalaby MA; Nounou HA; Ms A; O A; Azzam N; Saeed HM
Asian Pac J Cancer Prev; 2014; 15(12):4989-94. PubMed ID: 24998576
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in genes related to inflammation and obesity and colorectal adenoma risk.
Huang BZ; Tsilidis KK; Smith MW; Hoffman-Bolton J; Visvanathan K; Platz EA; Joshu CE
Mol Carcinog; 2018 Oct; 57(10):1278-1288. PubMed ID: 29802748
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia.
Kleinstein SE; Heath L; Makar KW; Poole EM; Seufert BL; Slattery ML; Xiao L; Duggan DJ; Hsu L; Curtin K; Koepl L; Muehling J; Taverna D; Caan BJ; Carlson CS; Potter JD; Ulrich CM
Genes Chromosomes Cancer; 2013 May; 52(5):437-49. PubMed ID: 23404351
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies.
Peng Q; Yang S; Lao X; Tang W; Chen Z; Lai H; Wang J; Sui J; Qin X; Li S
PLoS One; 2014; 9(4):e94790. PubMed ID: 24733273
[TBL] [Abstract][Full Text] [Related]
16. Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma.
Peters U; Chatterjee N; Hayes RB; Schoen RE; Wang Y; Chanock SJ; Foster CB
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1144-54. PubMed ID: 18483336
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma.
Poole EM; Hsu L; Xiao L; Kulmacz RJ; Carlson CS; Rabinovitch PS; Makar KW; Potter JD; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):547-57. PubMed ID: 20086108
[TBL] [Abstract][Full Text] [Related]
18. Associations of mitochondrial polymorphisms with sporadic colorectal adenoma.
Thyagarajan B; Guan W; Fedirko V; Barcelo H; Ramasubramaian R; Gross M; Goodman M; Bostick RM
Mol Carcinog; 2018 May; 57(5):598-605. PubMed ID: 29323753
[TBL] [Abstract][Full Text] [Related]
19. MTHFR (C677T and A1298C) polymorphisms and risk of sporadic distal colorectal adenoma in the UK Flexible Sigmoidoscopy Screening Trial (United Kingdom).
Mitrou PN; Watson MA; Loktionov AS; Cardwell C; Gunter MJ; Atkin WS; Macklin CP; Cecil T; Bishop TD; Primrose J; Bingham SA
Cancer Causes Control; 2006 Aug; 17(6):793-801. PubMed ID: 16783607
[TBL] [Abstract][Full Text] [Related]
20. Inflammation-related gene polymorphisms and colorectal adenoma.
Gunter MJ; Canzian F; Landi S; Chanock SJ; Sinha R; Rothman N
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1126-31. PubMed ID: 16775170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
